EUVIMEDEUVIMED entdecken
Systematische Übersicht

Semaglutide: Systematic Review with ☸️SAIMSARA

SAIMSARA Journal · 2026

DOI: 10.62487/saimsara45190890 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift SAIMSARA Journal, 2026. Die Arbeit nennt 247 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this systematic review is to comprehensively evaluate the diverse therapeutic applications, safety profile, and societal impact of semaglutide, synthesizing findings from recent academic literature to identify key clinical implications and future research directions. The review utilises 1454 original studies with 15874088 total participants (naïve ΣN). Semaglutide has emerged as a highly effective and versatile therapeutic agent, demonstrating significant benefits across a broad spectrum of conditions, most notably achieving a median body weight reduction of approximately 12.4% in adults with overweight or obesity. Its established efficacy in glycemic control, substantial cardiovascular and renal protective effects, and promising applications in liver and neurodegenerative diseases underscore its transformative role in modern medicine. While generally well-tolerated, the prevalence of gastrointestinal adverse events and concerns regarding equitable access remain important considerations. Future research should focus on optimizing long-term body composition outcomes and further elucidating its neuroprotective mechanisms, ensuring that the full potential of semaglutide is realized for all eligible patients.

Zitieren

APA

(2026). Semaglutide: Systematic Review with ☸️SAIMSARA. SAIMSARA Journal. https://doi.org/10.62487/saimsara45190890

Vancouver

Semaglutide: Systematic Review with ☸️SAIMSARA. SAIMSARA Journal. 2026. doi:10.62487/saimsara45190890

BibTeX
@article{euvimed2026,
  title = {Semaglutide: Systematic Review with ☸️SAIMSARA},
  journal = {SAIMSARA Journal},
  year = {2026},
  doi = {10.62487/saimsara45190890}
}
Kostenlos starten →